Elopak ASA
OSE:ELO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
35.9
52.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ELO stock under the Base Case scenario is 66.13 NOK. Compared to the current market price of 48.65 NOK, Elopak ASA is Undervalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Elopak ASA.
| US |
W
|
Westrock Co
LSE:0LW9
|
|
| US |
|
International Paper Co
NYSE:IP
|
|
| UK |
|
Amcor PLC
NYSE:AMCR
|
|
| US |
|
Packaging Corp of America
NYSE:PKG
|
|
| US |
|
Avery Dennison Corp
NYSE:AVY
|
|
| UK |
|
DS Smith PLC
LSE:SMDS
|
|
| IE |
S
|
Smurfit Kappa Group PLC
F:SK3
|
|
| US |
|
Sealed Air Corp
NYSE:SEE
|
|
| CH |
|
SIG Group AG
SIX:SIGN
|
|
| US |
|
Graphic Packaging Holding Co
NYSE:GPK
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Elopak ASA
Balance Sheet Decomposition
Elopak ASA
| Current Assets | 469.8m |
| Cash & Short-Term Investments | 39.1m |
| Receivables | 111.7m |
| Other Current Assets | 318.9m |
| Non-Current Assets | 585.3m |
| Long-Term Investments | 41.2m |
| PP&E | 356.2m |
| Intangibles | 152.4m |
| Other Non-Current Assets | 35.4m |
| Current Liabilities | 320.7m |
| Accounts Payable | 70.1m |
| Short-Term Debt | 41.5m |
| Other Current Liabilities | 209.1m |
| Non-Current Liabilities | 391.7m |
| Long-Term Debt | 358.9m |
| Other Non-Current Liabilities | 32.9m |
Free Cash Flow Analysis
Elopak ASA
| EUR | |
| Free Cash Flow | EUR |
Earnings Waterfall
Elopak ASA
|
Revenue
|
1.2B
EUR
|
|
Cost of Revenue
|
-722.8m
EUR
|
|
Gross Profit
|
450.3m
EUR
|
|
Operating Expenses
|
-345.2m
EUR
|
|
Operating Income
|
105.1m
EUR
|
|
Other Expenses
|
-52.3m
EUR
|
|
Net Income
|
52.7m
EUR
|
ELO Profitability Score
Profitability Due Diligence
Elopak ASA's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Elopak ASA's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
ELO Solvency Score
Solvency Due Diligence
Elopak ASA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Elopak ASA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ELO Price Targets Summary
Elopak ASA
According to Wall Street analysts, the average 1-year price target for ELO is 54.67 NOK with a low forecast of 44.44 NOK and a high forecast of 63 NOK.
Dividends
Current shareholder yield for ELO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ELO stock under the Base Case scenario is 66.13 NOK.
Compared to the current market price of 48.65 NOK, Elopak ASA is Undervalued by 26%.